Drug class in one race
Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs for Schizophrenia
27 tracked Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs in the Schizophrenia race. The class explanation lives on the Dopamine D2 and serotonin 5-HT2A receptors (antagonist) page; the full indication pipeline across every mechanism is on the Schizophrenia page.
23 approved / phase 43 Phase 31 preclinical / unstaged
Head-to-head evidence: Asenapine vs Clozapine · Asenapine vs Fazaclo · Asenapine vs Iloperidone (PD psychosis use) · Asenapine vs Loxapine (Adasuve) · Asenapine vs Lurasidone · Asenapine vs Milsaperidone (VHX-896)
The roster
← all Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs